Risk-based Monitoring (RBM) Software Market Size, Share & Trends Analysis Report, By Type (Enterprise RBM Software,Site RBM Software), By Application (Pharmaceutical & Biopharmaceutical Companies,CROs,Medical Device Companies,Other End Users), Regional Outlook and Forecast to 2028

Report Summary

Eternity Insights has published a new study on Global Risk-based Monitoring (RBM) Software Market focusing on key segments as by Type (Enterprise RBM Software, Site RBM Software, Other), by Application (Pharmaceutical & Biopharmaceutical Companies, CROs, Medical Device Companies, Other End Users), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Risk-based Monitoring (RBM) Software Market.

The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.

Risk-based Monitoring (RBM) Software Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.

Global Risk-based Monitoring (RBM) Software Market Size, 2018-2028 (USD Million)

Global Risk-based Monitoring (RBM) Software Market Segmentation:

Risk-based Monitoring (RBM) Software Market, By Type

• Enterprise RBM Software
• Site RBM Software
• Other

Risk-based Monitoring (RBM) Software Market, By Application

• Pharmaceutical & Biopharmaceutical Companies
• CROs
• Medical Device Companies
• Other End Users

Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Risk-based Monitoring (RBM) Software market in terms of demand generation. The Risk-based Monitoring (RBM) Software market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Risk-based Monitoring (RBM) Software market for below listed coun-tries across each region.

North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).

Global Risk-based Monitoring (RBM) Software Market Taxonomy:

Global Risk-based Monitoring (RBM) Software Market Competitive Landscape

The global Risk-based Monitoring (RBM) Software market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details

• Company Overview
• Financial Analysis
• Product Portfolio Analysis
• Strategic Overview
• SWOT Analysis

List of Companies Profiled in the report:

• Major 20 players included
• including Oracle (US)
• Medidata Solutions (US)
• Parexel (US)
• Bioclinica (US)
• Bio-Optronics (US)
• IBM Corporation (US)
• DATATRAK (US)
• Veeva Systems (US)
• DSG (US)
• MasterControl (US)
• ERT (US)
• Forte Research Systems (US)
• MedNet Solutions (US)
• ArisGlobal (US)
• Anju Software (US)
• MaxisIT (US)
• Techsol Corporation (US)
• OpenClinica (US)
• CRF Health (US)
• and Covance (US).
• Other Players of Specific Interest can be added based on requirement

Market Segmentation

Key Benefits to the stake holders

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come

Table Of Contents

1 Methodology and Scope

1.1 Market segmentation & scope
1.2 Information Procurement

1.2.1 Purchased Database
1.2.2 Eternity’s Internal Database
1.2.3 Secondary sources & third-party perspectives
1.2.4 Primary Research

1.3 Information analysis
1.4 Market formulation & data visualization
1.5 Data validation & publishing

2 Executive Summary

3 Risk-based Monitoring (RBM) Software Market Variables, Trends & Scope

3.1 Market Dynamics

3.1.1 Market Driver Analysis
3.1.2 Market Restraints
3.1.3 Market Challenge Analysis
3.1.4 Market Opportunities
3.1.5 Micro & Macro Indicator

3.2 Impact of COVID-19 Pandemic on Global Risk-based Monitoring (RBM) Software Market

3.2.1 Overview of Changing Landscape
3.2.2 Pre-covid & Post-Covid Market Analysis

3.3 Market Attractiveness Analysis
3.4 Regulatory Scenario
3.5 Industry Trend Analysis- Historic and Future Trend Assessment
3.6 Merger & Acquisition
3.7 New System Launch/Approvals
3.8 Market Analysis Tools

3.8.1 Porter’s Five Forces
3.8.2 PEST Analysis
3.8.3 Value Chain Analysis

3.9 Key Company Ranking Analysis, 2020

4 Global Risk-based Monitoring (RBM) Software Market Analysis and Forecast, By Type

4.1 Overview & Definition
4.2 Key Trends
4.3 Global Risk-based Monitoring (RBM) Software Market Value (US$ Mn) Forecast, by Type (2019 – 2028)

4.2.1 Enterprise RBM Software
4.2.2 Site RBM Software
4.2.3 Other

4.4 Type Comparison Matrix
4.5 Global Risk-based Monitoring (RBM) Software Market Attractiveness, By Type

5 Global Risk-based Monitoring (RBM) Software Market Analysis and Forecast, By Application

5.1 Overview & Definition
5.2 Key Trends
5.3 Global Risk-based Monitoring (RBM) Software Market Value (US$ Mn) Forecast, by Application (2019 – 2028)

5.3.1 Pharmaceutical & Biopharmaceutical Companies
5.3.2 CROs
5.3.3 Medical Device Companies
5.3.4 Other End Users

5.4 Application Comparison Matrix
5.5 Global Risk-based Monitoring (RBM) Software Market Attractiveness, by Application

6 Global Risk-based Monitoring (RBM) Software Market Analysis and Forecast, By Region

6.1 Overview & Definition
6.2 Key Trends
6.3 Global Risk-based Monitoring (RBM) Software Market Value (US$ Mn) Forecast, by Region (2019 – 2028)
6.4 North America
6.5 Europe
6.6 Asia Pacific
6.7 Latin America
6.8 Middle East & Africa

7 Global Risk-based Monitoring (RBM) Software Market Attractiveness, by Region

8 North America Risk-based Monitoring (RBM) Software Market Analysis and Forecast

8.1 Key Findings
8.2 North America Risk-based Monitoring (RBM) Software Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)

8.2.1 Enterprise RBM Software
8.2.2 Site RBM Software
8.2.3 Other

8.3 North America Risk-based Monitoring (RBM) Software Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)

8.3.1 Pharmaceutical & Biopharmaceutical Companies
8.3.2 CROs
8.3.3 Medical Device Companies
8.3.4 Other End Users

8.4 North America Risk-based Monitoring (RBM) Software Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)

8.4.1 U.S.
8.4.2 Canada
8.4.3 Rest of North America

8.5 North America Risk-based Monitoring (RBM) Software Market Attractiveness Analysis

8.5.1 By Type
8.5.2 By Application
8.5.3 By Country

9 Europe Risk-based Monitoring (RBM) Software Market Analysis and Forecast

9.1 Key Findings
9.2 Europe Risk-based Monitoring (RBM) Software Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)

9.2.1 Enterprise RBM Software
9.2.2 Site RBM Software
9.2.3 Other

9.3 Europe Risk-based Monitoring (RBM) Software Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)

9.3.1 Pharmaceutical & Biopharmaceutical Companies
9.3.2 CROs
9.3.3 Medical Device Companies
9.3.4 Other End Users

9.4 Europe Risk-based Monitoring (RBM) Software Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)

9.4.1 U.K.
9.4.2 Germany
9.4.3 France
9.4.4 Italy
9.4.5 Rest of Europe

9.5 Europe Risk-based Monitoring (RBM) Software Market Attractiveness Analysis

9.5.1 By Type
9.5.2 By Application
9.5.3 By Country

10 Asia Pacific Risk-based Monitoring (RBM) Software Market Analysis and Forecast

10.1 Key Findings
10.2 Asia Pacific Risk-based Monitoring (RBM) Software Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)

10.2.1 Enterprise RBM Software
10.2.2 Site RBM Software
10.2.3 Other

10.3 Asia Pacific Risk-based Monitoring (RBM) Software Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)

10.3.1 Pharmaceutical & Biopharmaceutical Companies
10.3.2 CROs
10.3.3 Medical Device Companies
10.3.4 Other End Users

10.4 Asia Pacific Risk-based Monitoring (RBM) Software Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)

10.4.1 China
10.4.2 India
10.4.3 Japan
10.4.4 South Korea
10.4.5 Rest of APAC

10.5 Asia Pacific Risk-based Monitoring (RBM) Software Market Attractiveness Analysis

10.5.1 By Type
10.5.2 By Application
10.5.3 By Country

11 Latin America Risk-based Monitoring (RBM) Software Market Analysis and Forecast

11.1 Key Findings
11.2 Latin America Risk-based Monitoring (RBM) Software Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)

11.2.1 Enterprise RBM Software
11.2.2 Site RBM Software
11.2.3 Other

11.3 Latin America Risk-based Monitoring (RBM) Software Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)

11.3.1 Pharmaceutical & Biopharmaceutical Companies
11.3.2 CROs
11.3.3 Medical Device Companies
11.3.4 Other End Users

11.4 Latin America Risk-based Monitoring (RBM) Software Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)

11.4.1 Brazil
11.4.2 Rest of Latin America China

11.5 Latin America Risk-based Monitoring (RBM) Software Market Attractiveness Analysis

11.5.1 By Type
11.5.2 By Application
11.5.3 By Country

12 Middle East & Africa (MEA) Risk-based Monitoring (RBM) Software Market Analysis and Forecast

12.1 Key Findings
12.2 Middle East & Africa (MEA) Risk-based Monitoring (RBM) Software Market Analysis (US$ Mn) and Forecast, By Product Type (2019-2028)

12.2.1 Enterprise RBM Software
12.2.2 Site RBM Software
12.2.3 Other

12.3 Middle East & Africa (MEA) Risk-based Monitoring (RBM) Software Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)

12.3.1 Pharmaceutical & Biopharmaceutical Companies
12.3.2 CROs
12.3.3 Medical Device Companies
12.3.4 Other End Users

12.4 Middle East & Africa (MEA) Risk-based Monitoring (RBM) Software Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)

12.4.1 GCC Countries
12.4.2 South Africa
12.4.3 Rest of MEA

12.5 Middle East & Africa (MEA) Risk-based Monitoring (RBM) Software Market Attractiveness Analysis

12.5.1 By Type
12.5.2 By Application
12.5.3 By Country

13 Competitive Landscape

13.1 Market Players – Competition Matrix
13.2 Market Share Analysis by Key Players, 2020 (%)
13.3 Company Profiles

13.3.1 Major 20 players included

13.3.1.1 Company Overview
13.3.1.2 Company Snapshot
13.3.1.3 Financial Overview
13.3.1.4 Product Portfolio
13.3.1.5 Key Developments/Strategies

13.3.2 including Oracle (US)
13.3.3 Medidata Solutions (US)
13.3.4 Parexel (US)
13.3.5 Bioclinica (US)
13.3.6 Bio-Optronics (US)
13.3.7 IBM Corporation (US)
13.3.8 DATATRAK (US)
13.3.9 Veeva Systems (US)
13.3.10 DSG (US)
13.3.11 MasterControl (US)
13.3.12 ERT (US)
13.3.13 Forte Research Systems (US)
13.3.14 MedNet Solutions (US)
13.3.15 ArisGlobal (US)
13.3.16 Anju Software (US)
13.3.17 MaxisIT (US)
13.3.18 Techsol Corporation (US)
13.3.19 OpenClinica (US)
13.3.20 CRF Health (US)
13.3.21 and Covance (US).

14 Key Takeaways